The introduction of Apple Pay last Monday was widely described as the dawn of a new era for smartphone payments. But within a week, two major pharmacy chains, Rite Aid RAD and CVS CVS, rejected Apple’s AAPL version of the future: Both disabled Apple Pay as well as other tap-to-pay mobile payments systems Google Wallet and Softcard. As expected, customers took to Twitter to complain, and they almost universally sided with the smartphone company over the drugstores.
CVS hasn’t publicly explained itself. Rite Aid spokeswoman Ashley Flower defended the company in an e-mail to Bloomberg Businessweek. “We are continually evaluating various forms of mobile payment technologies, and are committed to offering convenient, reliable, and secure payment methods that meet the needs of our customers,” she wrote.